- Drug combo reduces death risk for aggressive prostate cancer The Indian Express
- EMBARK: “Unprecedented” Overall Survival Urology Times
- Stephen Freedland, MD, discusses significance of EMBARK OS data Urology Times
Drug combo reduces death risk for aggressive prostate cancer The Indian ExpressEMBARK: “Unprecedented” Overall Survival Urology TimesStephen Freedland, MD, discusses significance of EMBARK OS data Urology Times by Soban News (international And National News)
